AP NEWS
ADVERTISEMENT
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In ...

June 28, 2021 GMT

PHILADELPHIA, June 28, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athira Pharma, Inc. (“Athira” or the “Company”) ( NASDAQ: ATHA ) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Class action lawsuits have been filed in United States District Court on behalf of purchasers of the securities of Athira (a) pursuant and/or traceable to the Company’s initial public offering (“IPO”) conducted in September 2020; and/or (b) between September 18, 2020 and June 17, 2021, both dates inclusive (the “Class Period”).

ADVERTISEMENT

According to the lawsuits, the IPO documents contained and defendants made false and/or misleading statements and/or failed to disclose that (1) the research conducted by the Company’s Chief Executive Officer and President, Leen Kawas (“Kawas”), was tainted by Kawas’ scientific misconduct, including the manipulation of key data through the altering of Western blot images; (2) this purported research was foundational to Athira’s efforts to develop treatments for Alzheimer’s because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer’s; (3) as a result, Athira’s intellectual property and product development for the treatment of Alzheimer’s was based on invalid research; and (4) as a result of the foregoing, the Athira defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

ADVERTISEMENT

INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATHIRA SECURITIES PURSUANT AND/OR TRACEABLE TO ATHIRA’S IPO AND/OR DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., MYARNOFF@KEHOELAWFIRM.COM, SECURITIES@KEHOELAWFIRM.COM, INFO@KEHOELAWFIRM.COM, TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct.  Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.   

This press release may constitute attorney advertising.